PerkinElmer Inc. (PerkinElmer), is a leading manufacture of products, services and solutions for In Vitro Diagnostics, headquartered in the United States with global manufacturing and sales reach. PerkinElmer's product range includes the newly launched COVID-19 RT-PCR Test in its In Vitro Diagnostics segment, which is approved by FDA and now available in 30 countries worldwide. The report, COVID-19 Impact on PerkinElmer Inc.'s Revenue and Operations (Medical Devices) presents a deep dive analysis into how PerkinElmer Inc. is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.
The report provides a comprehensive analysis of the impact of COVID-19 on PerkinElmer Inc. –
– It provides insights on PerkinElmer Inc.'s exposure to the regions and businesses impacted by the COVID-19 outbreak.
– It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.
While PerkinElmer was impacted early on in APAC due to the COVID-19 crisis, the company’s global performance has been positive in all regions. The geographic diversification of PerkinElmer's business has been beneficial for generating revenue. With improved conditions in APAC, PerkinElmer has recuperated revenue from resumed sales in this region.
Reasons to Buy
An overview of how PerkinElmer Inc. will be affected by the COVID-19 pandemic.
Table of Contents
Table of Contents
COVID-19 impact analysis on PerkinElmer Inc. – Key Findings
PerkinElmer Inc. Key Facts
Geographic spread analysis – COVID-19 vs PerkinElmer Inc. sales
The impact of COVID-19 on regional GDP per capita levels
PerkinElmer Inc. exposure: revenues by region and market vs regional impact levels
PerkinElmer Inc. : revenue impact by region and market for 2020
Operational reactions from PerkinElmer Inc. Indications from recruitment trends
Operational reactions from PerkinElmer’s Indications from US pricing trends